Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed)

Published: 20 November 2024
Categories: National Institute of Health-Grants

Link to the full source article

RSS feed source: National Institute of Health

Participating Organization(s)

National Institutes of Health (NIH)

Components of Participating Organizations

National Institute on Drug Abuse (NIDA)

National Institute of Allergy and Infectious Diseases (NIAID)

Funding Opportunity Title

Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed)

Activity Code

R01 Research Project Grant

Announcement Type

Related Notices

April 4, 2024 – Overview of Grant Application and Review Changes for Due Dates on or after January 25, 2025. See Notice NOT-OD-24-084. August 31, 2022 – Implementation Changes for Genomic Data Sharing Plans Included with Applications Due on or after January 25, 2023. See Notice NOT-OD-22-198.August 5, 2022 – Implementation Details for

Click this link to continue reading the article on the source website.